PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020278
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2020278
The global echocardiography market, which encompasses devices used to perform cardiac ultrasounds, was valued at USD 2.13 billion in 2025 and is projected to grow to USD 2.29 billion in 2026, ultimately reaching USD 4.07 billion by 2034, reflecting a CAGR of 7.45% during the forecast period of 2026-2034. North America dominated the market in 2025 with a 24.85% share, driven by the rising prevalence of coronary and peripheral heart diseases, an increasing geriatric population, and strong presence of key industry players.
Echocardiography, also referred to as an echo or cardiac ultrasound, utilizes sound waves to create images of the heart for detecting cardiovascular diseases. The technology allows the identification of blood clots, assessment of heart chambers, and evaluation of valves. Among various tests, transthoracic echocardiography is the most common due to its non-invasive nature. Other modalities include transesophageal and stress echocardiography, used for specialized diagnostic purposes.
Market Growth Drivers
The market growth is primarily fueled by the rising burden of heart-related disorders and the increasing demand for non-invasive diagnostic procedures. Cardiovascular conditions such as heart arrhythmias, valve diseases, heart failure, and pericardial diseases are increasing globally due to sedentary lifestyles, unhealthy diets, and smoking. According to the CDC, approximately 805,000 people in the U.S. experience a heart attack annually, with 605,000 being first-time events. In Europe, over half of all deaths are linked to cardiovascular disease, contributing to more than 60 million potential years of life lost each year.
Early detection initiatives and preventive healthcare programs also support market growth. Programs such as Million Hearts, co-led by the U.S. CDC and CMS, aim to reduce myocardial infarction and cardiac stroke rates by 2027, boosting demand for echocardiography devices. The non-invasive nature of these devices provides advantages over other cardiac diagnostic procedures like cardiac catheterization, MRI, or nuclear stress tests, which carry higher risks and costs. Echocardiography is also extensively used in monitoring patients undergoing cancer treatment due to cardiotoxicity risks.
Technological Advancements
Technological innovation, particularly the incorporation of AI and 3D/4D imaging, is enhancing the market potential. AI improves diagnostic accuracy, workflow efficiency, and patient outcomes. For example, in December 2021, Koninklijke Philips N.V. launched an AI-driven auto-measure application in its EPIQ CVx and Affiniti CVx systems, reducing measurement time by half. Similarly, Ultromics and Pfizer received FDA clearance in January 2024 for the EchoGo Amyloidosis AI algorithm.
The adoption of handheld devices and point-of-care solutions is also rising. In June 2022, Clarius Mobile Health partnered with ImaCor Inc. to launch a handheld transesophageal cardiac ultrasound scanner for ICU patients. These innovations improve access and convenience, driving demand across hospitals and diagnostic centers.
Market Segmentation
Key Players
Major companies in the echocardiography market include:
These companies are actively involved in R&D, new product launches, and AI integration to enhance diagnostic efficiency and expand market share.
Market Restraints
Despite growth, high device costs (ranging from USD 20,000 to 100,000) and limitations in handheld devices, such as smaller screens and lower resolution, may restrict adoption in certain regions. Echocardiogram procedures can cost between USD 1,000 to over USD 3,000, depending on test type, insurance, and healthcare facility.
Conclusion
The echocardiography market is poised for robust growth from 2026 to 2034, driven by the rising prevalence of cardiovascular diseases, demand for non-invasive diagnostics, technological advancements in AI and 3D imaging, and increased adoption in hospitals and diagnostic centers worldwide.
Growth Rate CAGR of 7.45% from 2026-2034
Segmentation By Device Type
By Test Type
By Technology
By End-user
By Geography